ArticleDiscover oncology2024

Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia.

Xiaohuan Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.